Supplementary Data
SUPPLEMENTARY DATA Investigators participating in Study H8O-EW-GWDL, Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes (NCT01003184) Peter Harvey, Addlestone, England, United Kingdom Sharon Gillings, Bath, England, United Kingdom Srikanth Bellary, Birmingham, England, United Kingdom Shenaz Ramtoola, Blackburn, England, United Kingdom David Kerr, Bournemouth, England, United Kingdom Tristan Richardson, Bournemouth, England, United Kingdom Richard Gaunt, Chippenham, England, United Kingdom Garry Tan, Derby, England, United Kingdom Mark Daly, Exeter, England, United Kingdom Ian Gallen, High Wycombe, England, United Kingdom Stephen Atkin, Hull, England, United Kingdom Melanie Davies, Leicester, England, United Kingdom Abdul Lakhdar, Leytonstone, United Kingdom Karen Adamson, Livingston, United Kingdom Jiten Vora, Liverpool, England, United Kingdom Chidambaram Nethaji, London, England, United Kingdom William Stephens, Manchester, England, United Kingdom Niall Furlong, Merseyside, England, United Kingdom Stephen Jones, Middlesborough, England, United Kingdom Vijayaraman Arutchelvam, Middlesborough, England, United Kingdom Philip Home, Newcastle, England, United Kingdom Charles Fox, Northampton, England, United Kingdom Deepak Bhatnagar, Oldham, England, United Kingdom Ann Millward, Plymouth, England, United Kingdom Michael Cummings, Portsmouth, England, United Kingdom Simon Heller, Sheffield, England, United Kingdom Aide Viljoen, Stevenage, England, United Kingdom Gerrard Rayman, Suffolk,
[Show full text]